- Home
- CERT vs ORIC Comparison
CERT vs ORIC Comparison
Compare CERT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CERT | ORIC |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.9M | 861.3M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CERT | ORIC |
|---|---|---|
| Price | $5.90 | $8.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | $11.67 | ★ $19.73 |
| AVG Volume (30 Days) | ★ 3.5M | 1.0M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,838,000.00 | N/A |
| Revenue This Year | $4.18 | N/A |
| Revenue Next Year | $5.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $4.45 | $7.23 |
| 52 Week High | $13.88 | $14.93 |
Technical Indicators
Market Signals| Indicator | CERT | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 58.09 | 39.95 |
| Support Level | $5.19 | $7.83 |
| Resistance Level | $6.47 | $11.22 |
| Average True Range (ATR) | 0.36 | 0.43 |
| MACD | 0.11 | 0.07 |
| Stochastic Oscillator | 88.68 | 48.22 |
Price Performance
Historical ComparisonAbout CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.